FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

CMS Questions FDA Aduhelm Approval: Analysis

Washington University in St. Louis law professor Rachel Sachs says a CMS restricted coverage determination for Biogens Aduhelm adds to questions about...

Human Drugs

Novartis Seeking EUA for Covid Therapeutic

Novartis and Molecular Partners say they plan to seek an FDA emergency use authorization after reporting results from the EMPATHY clinical trial that...

Human Drugs

Skinny Label Allowed Faster Generic Entry: Study

Harvard Medical School researchers say the use of skinny labeling in generic forms of Novartis Gleevec allowed the generics to enter the market before...

Human Drugs

FDA Accepts PharmaTher Ketamine IND for ALS

FDA accepts an IND for a PharmaTher Phase 2 trial of ketamine to treat ALS.

Federal Register

Final Rule Revokes Older Human Tissue Regs

Federal Register notice: FDA issues a final rule to revoke the regulations for human tissue intended for transplantation and human dura mater recovere...

Federal Register

Final Rule on PMA/HDE Device Announcements

Federal Register notice: FDA issues a final rule to amend the medical device regulations on procedures for announcing approvals and denials of PMAs an...

Medical Devices

Abbott Cardiac Arrhythmia Mapping Platform Cleared

FDA clears an Abbott 510(k) for the EnSite EP System with EnSite Omnipolar Technology, a new cardiac mapping platform designed to help physicians bett...

Human Drugs

7 Observations in Med Shop Total Care FDA-483

FDA releases an FDA-483 with seven observations from an inspection at Longview, TX-based Med Shop Total Care.

Federal Register

Corrected Regulatory Review Period for Enhertu

Federal Register notice: FDA corrects a notice in the 11/1/2021 Federal Register that announced the regulatory review period for Daiichi Sankyos Enher...

Medical Devices

FDA Warns Against LuSys Covid Tests

FDA warns against using unapproved LuSys Laboratories Covid-19 tests due to a potentially high risk of false results.